Furthermore, upon completion of TB treatment, levels of soluble analytes normalized; last, we showed that in PWH, assessing the expression of HLA-DR on Mtb-specific CD4 T cells had a better potential to discriminate PCTB and PTB from LTBI compared to biosignatures derived from soluble markers. This evidence concerns the gene CD4 and tuberculosis.